SGH

Sivik Global Healthcare Portfolio holdings

AUM $224M
This Quarter Return
+1.77%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$224M
AUM Growth
+$224M
Cap. Flow
+$35.1M
Cap. Flow %
15.71%
Top 10 Hldgs %
46.72%
Holding
49
New
10
Increased
17
Reduced
7
Closed
1

Top Buys

1
DGX icon
Quest Diagnostics
DGX
$4.49M
2
RVTY icon
Revvity
RVTY
$4.35M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
$4.34M
4
RGEN icon
Repligen
RGEN
$3.73M
5
UHS icon
Universal Health Services
UHS
$3.62M

Top Sells

1
AZN icon
AstraZeneca
AZN
$5.15M
2
EHC icon
Encompass Health
EHC
$3.26M
3
BAX icon
Baxter International
BAX
$3.03M
4
BSX icon
Boston Scientific
BSX
$2.15M
5
CAH icon
Cardinal Health
CAH
$840K

Sector Composition

1 Healthcare 90.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SNN icon
26
Smith & Nephew
SNN
$16.2B
$4.29M 1.17%
140,000
+20,000
+17% +$613K
RGEN icon
27
Repligen
RGEN
$6.54B
$3.73M 1.02%
+30,000
New +$3.73M
WST icon
28
West Pharmaceutical
WST
$17.9B
$3.28M 0.89%
15,000
+2,500
+20% +$547K
EHC icon
29
Encompass Health
EHC
$12.5B
$3.07M 0.83%
25,000
-26,600
-52% -$3.26M
AVTR icon
30
Avantor
AVTR
$8.74B
$3.03M 0.82%
225,000
+25,000
+13% +$337K
ALGN icon
31
Align Technology
ALGN
$9.59B
$2.84M 0.77%
+15,000
New +$2.84M
SGRY icon
32
Surgery Partners
SGRY
$2.89B
$2.78M 0.76%
125,000
– –
BAX icon
33
Baxter International
BAX
$12.1B
$2.27M 0.62%
75,000
-100,000
-57% -$3.03M
COO icon
34
Cooper Companies
COO
$13.3B
$2.14M 0.58%
+30,000
New +$2.14M
ALNY icon
35
Alnylam Pharmaceuticals
ALNY
$58.6B
$2.12M 0.58%
+6,500
New +$2.12M
MDGL icon
36
Madrigal Pharmaceuticals
MDGL
$9.7B
$1.51M 0.41%
+5,000
New +$1.51M
ARGX icon
37
argenx
ARGX
$44.2B
$1.38M 0.37%
+2,500
New +$1.38M
INSP icon
38
Inspire Medical Systems
INSP
$2.53B
$1.3M 0.35%
+10,000
New +$1.3M
SRPT icon
39
Sarepta Therapeutics
SRPT
$1.98B
– –
0
– –
AZN icon
40
AstraZeneca
AZN
$255B
– –
-70,000
Closed -$5.15M
1
2